96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Synthetic anti-inflammatory peptides and use thereof
#3002Peptoid affinity ligands
#3003LLP2A-bisphosphonate conjugates for osteoporosis treatment
#3004POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE
#3005Anti-tumor polypeptides and method for preparing anti-tumor drugs comprisng the same
#3006Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
#3007Modulators of the SRC-kinase activity for preventing or treating metastatic cancer
#3008Microwave-assisted peptide synthesis
#3009Composition for delivery of genetic material
#3010Compounds, substrates and methods related to histone deacetylases
#3011Therapeutic DLL4 binding proteins
#3012Biologically active peptides
#3013Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#3014Compositions and method for treating thrombosis
#3015Self-assembling peptide and polysaccharide complexes
#3016Methods, uses and compositions of Tie2 agonists
#3017Methods and systems for designing and/or characterizing soluble lipidated ligand agents
#3018CRP40 FRAGMENTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#3019Templates for controlling synthesis of nanoparticles into discrete assemblies
#3020BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE
#3021Use of inhibitory peptides for the treatment of inflammatory diseases
#3022Immunogenic epitopes for immunotherapy
#3023Anti-angiogenic peptides and uses thereof
#3024Modulation of structured polypeptide specificity
#3025βsheet tapes ribbons in tissue engineering
#3026Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide
#3027Targeting peptides and uses thereof
#3028Peptide Ligand with Antibody Selectivity and the Application Thereof
#3029Inhibitors of TLR signaling by targeting TIR domain interfaces
#3030Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
#3031REGULATING BACILLUS ANTHRACIS LETHAL FACTOR ACTIVITY VIA AN ACTIVATING EPITOPE REGION
#3032Peptides with antifungal activity and methods of using the peptides
#3033Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
#3034Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
#3035Methods for Selecting Peptides that Bind to Disease Specific Antibodies, Disease Specific Peptides and Uses Thereof
#3036Use of GPR83 to identify pruritus-related substances
#3037Amyloidosis-inhibiting polypeptides and their use
#3038RHAMM binding peptides
#3039Modification of polypeptides
#3040Peptide selectively binding to graphitic materials and volatile organic compounds
#3041NEURAL REGENERATION PEPTIDES AND USES THEREFOR
#3042Triazole macrocycle systems
#3043COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS
#3044Stapled and stitched polypeptides and uses thereof
#3045CD44V6-derived peptides for treating breast cancer
#3046Selective inhibitor of angiotensin II
#3047Epitope and its use
#3048Peptides that Selectively Home to Heart Vasculature and Related Conjugates and Methods
#3049MHC-I restricted epitopes containing non-natural amino acid residues
#3050Process for preparing eptifibatide
#3051Ang-(1-7) derivative oligopeptides and methods for using and producing the same
#3052Tunable control of protein degradation in synthetic and endogenous bacterial systems
#3053Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof
#3054DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS
#3055Method of Forming Fragment Ligated Inhibitors
#3056PEPTIDE MOLECULAR MATERIALS
#3057KNTC2 peptides and vaccines containing the same
#3058Methods and compositions for the treatment of bone remodeling disorders
#3059Methods and compositions for targeting adipose cells in mammals
#3060IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#3061Compositions and methods for modulating gamma-C-cytokine activity
#3062Molecule library constructed on the basis of backbone structure of microprotein
#3063PEPTOIDS THAT BIND SPECIFIC ANTIGENS
#3064Enhanced AAV-mediated gene transfer for retinal therapies
#3065Peptidomimetics possessing photo-controlled biological activity
#3066Peptides for the Treatment of Immune Reconstitution Inflammatory Syndrome (IRIS) and Related Diseases
#3067Compositions and methods for detecting plectin-1 as a biomarker for cancer
#3068TOMM34 peptides and vaccines including the same
#3069HIGH-SENSITIVE FLUORESCENT ENERGY TRANSFER ASSAY USING FLUORESCENT AMINO ACIDS AND FLUORESENT PROTEINS
#3070Antifouling materials
#3071Peptide inhibitor of Nox1 NADPH oxidase
#3072Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins
#3073Amyloid-beta binding proteins
#3074Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#3075Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same
#3076Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#3077Methods of determining levels of cleaved and/or intact kininogen
#3078Protein biosensors, cross reactive sensor arrays and methods of use thereof
#3079Mitochondria targeting peptide
#3080KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals
#3081Peptide inhibitors of nicotinic acetylcholine receptor
#3082TRH binding site in human CNS
#3083Polypeptide specifically binding to rare earth nanoparticles and use thereof
#3084Purification of organic compounds using surrogate stationary phases on reversed phase columns
#3085p53 activating peptides
#3086Autophagy-inducing peptide analogs
#3087Method for constructing a novel affinity peptide library for binding immunoglobulin G based on a protein affinity model of protein A
#3088Methods for binding and precipitating gold using microbial-derived metallophores and their uses
#3089Signal biomarkers
#3090Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#3091Antibody-binding peptide
#3092Peptidomimetic compounds
#3093Short bio-active peptides for promoting wound healing
#3094Compositions for labeling nerves and methods of use
#3095Endometriosis cell targeting peptide and uses thereof
#3096PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)
#3097Immunogenic WT-1 peptides and methods of use thereof
#3098MUTANT AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#3099CTL inducer composition
#3100Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions
#3101Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles
#3102Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#3103Albumin fusion proteins
#3104PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF SSDNA VIRUSES
#3105Synthesis of beta-arrestin effectors
#3106ALL GOLD FLUORESCENCE RESONANCE ENERGY TRANSFER PROBE AND USE THEREOF
#3107Azapeptides as CD36 binding compounds
#3108Targeting of EWS-FLI1 as anti-tumor therapy
#3109SELECTED REACTION MONITORING ASSAYS
#3110Anti-microbial activity of synthetic peptides
#3111SEMA5B PEPTIDES AND VACCINES CONTAINING THE SAME
#3112Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#3113TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK
#3114Saposin-A derived peptides and uses thereof
#3115METHOD FOR SCREENING A NUCLEIC ACID-PROGRAMMED SMALL MOLECULE LIBRARY
#3116Fragment ligated inhibitors selective for the polo box domain of PLK1
#3117Peptides and compositions for prevention of cell adhesion and methods of using same
#3118Small cationic antimicrobial peptides
#3119Method of inducing an immune response by administering WDRPUH epitope peptides
#3120MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#3121Vitamin receptor drug delivery conjugates for treating inflammation
#3122LINKER-PAYLOAD MOLECULE CONJUGATES
#3123Prion epitopes and methods of use thereof
#3124Quinone-masked probes as labeling reagents for cell uptake measurements
#3125Synthetic analogues of neural regeneration peptides
#3126NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
#3127Cytotoxic peptides and antibody drug conjugates thereof
#3128Peptide pharmaceuticals
#3129COPOLYMERS FOR THE DELIVERY OF DRUGS INTO CELLS
#3130Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same
#3131HMGB1-derived peptides enhance immune response to antigens
#3132Methods of protecting against apoptosis using lipopeptides
#3133EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF
#3134BINDING MOIETIES FOR BIOFILM REMEDIATION
#3135Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
#3136Beta sheet tapes ribbons in tissue engineering
#3137Inhibition of cardiac fibrosis in myocardial infarction
#3138Cyclic peptide and pharmaceutical product containing same
#3139Eptifibatide preparation method
#3140Polypeptide expressed in the stratum corneum and use thereof
#3141Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathies
#3142Bioactive peptide complexes
#3143COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS
#3144Polymers, pharmaceutical compositions and methods of synthesizing the same
#3145C4S proteoglycan specific transporter molecules
#3146COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS
#3147Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases
#3148Selective targeting agents for mitochondria
#3149TREATMENT OF CANCER BY TARGETING QUIESCENT CANCER CELLS
#3150Modified peptide, CB receptor ligand, kit in vitro process for evaluating CB receptor bonds, uses, pharmaceutical composition for modulating CB receptor activity
#3151Short interference RNA gene delivery system for systemic circulation
#3152NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF
#3153Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor
#3154Peptides that stimulate subcutaneous adipogenesis
#3155Application of SP peptide or derivative thereof in preparing medicines for preventing or treating asthma
#3156Hepcidin mimetic peptides and uses thereof
#3157Methods and agents for the treatment of cancer
#3158Macrocyclic compounds for inhibition of inhibitors of apoptosis
#3159Method for treating blood, blood products and organs
#3160Molecular sensor and methods of use thereof
#3161Stable and soluble antibodies inhibiting VEGF
#3162Gamma-AApeptides with potent and broad-spectrum antimicrobial activity
#3163Compositions and methods for regulating arterial tone
#3164Mucin hypersecretion inhibitors and methods of use
#3165HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1
#3166JNK inhibitor molecules
#3167DPP8 and DPP9 peptide inhibitors
#3168Peptide for reducing the phosphate requirement and excretion from farm animals
#3169BOMBESIN ANALOG PEPTIDE ANTAGONIST CONJUGATES
#3170FOXM1 peptide and medicinal agent comprising the same
#3171Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin
#3172Anti-Glypican 3 Antibody
#3173Peptides and compositions for prevention of cell adhesion and methods of using same
#3174Pharmaceutical composition for cancer prevention and treatment containing peptide originated from C12orf59 protein as an active ingredient
#3175Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation
#3176Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
#3177Drug delivery conjugates containing unnatural amino acids and methods for using
#3178Methods for the treatment of X-linked hypophosphatemia and related disorders
#3179TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same
#3180Point of care assays to detect the status of tuberculosis infection
#3181Methods and Compositions for Biomarkers of Fatigue, Fitness and Physical Performance Capacity
#3182Treatment of brain injury with a neurotrophic peptide
#3183NEUROPLASTIN DERIVED PEPTIDES
#3184Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes
#3185Therapy and kit for the prevention and treatment of cystic fibrosis
#3186Peptides for suppressing inflammation
#3187TRPV3 AGONISTS FOR THE TREATMENT OF SKIN CONDITIONS
#3188Methods and compositions for specific modulation of MCL-1
#3189Chimeric dystrophin-VSV-G protein to treat dystrophinopathies
#3190Polypeptides and antibodies for treating HBV infection and related diseases
#3191PEPTIDES AND METHODS FOR TREATING CANCER
#3192Peptides that bind to epithelial cell adhesion molecule
#3193MOESIN MODULATORS AND USES THEREOF
#3194Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
#3195Compositions and methods for measles virus inhibition
#3196Hydrogen bond surrogate macrocycles as modulators of Ras
#3197Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
#3198WT1 antigen peptide conjugate vaccine
#3199Compositions of GnRH related compounds and processes of preparation
#3200IAP antagonists
#3201Anti-tumour response to modified self-epitopes
#3202Compositions and methods for treating hepatitis B
#3203Method for producing a composition for treating a tooth lesion
#3204Aldehyde capture ligation technology for synthesis of amide bonds
#3205Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#3206COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE
#3207COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING
#3208Method for identifying novel minor histocompatibility antigens
#3209Crystalline and amorphous forms of a β-arrestin effector
#3210Synthetic artificial peptides with antimicrobial effect
#3211Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
#3212Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
#3213TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF
#3214Phosphorylated Akt-specific capture agents, compositions, and methods of using and making
#3215Intracellular organelle peptide targeted enzyme substrates
#3216Method of introducing nucleic acid into plant cells
#3217Inhibitors of the Epidermal Growth Factor Receptor- Heat Shock Protein 90 Binding Interaction
#3218Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation
#3219Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
#3220Medicaments
#3221Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#3222PSF1-derived peptide
#3223INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX
#3224Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#3225Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
#3226Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#3227Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#3228METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS
#3229INHIBITION OF GLIADIN PEPTIDES
#3230CD31 peptides
#3231Intestinal peptide targeting ligands
#3232Anti-androgen peptides and uses thereof in cancer therapy
#3233METHOD FOR ENHANCING TRANSPORT OF SEMICONDUCTOR NANOCRYSTALS ACROSS BIOLOGICAL MEMBRANES
#3234Compounds
#3235Bladder cancer specific ligand peptides
#3236CDCA1 epitope peptides for Th1 cells and vaccines containing the same
#3237KIF20A epitope peptides for TH1 cells and vaccines containing the same
#3238OSTEOPONTIN PEPTIDE FRAGMENTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH
#3239Systematic discovery, maturation and extension of peptide binders to proteins
#3240Peptide-hinge-free flexible antibody-like molecule
#3241RFamide-related peptides and methods thereof
#3242Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof
#3243CD44v6-derived peptides for treating metastasizing cancer
#3244Synzymes
#3245Therapeutic agents for reducing parathyroid hormone levels
#3246Process for producing self-assembling peptide derivatives
#3247Peptides and use thereof
#3248Controlled modulation of amino acid side chain length of peptide antigens
#3249Peptide derivatives as antibiotics
#3250Induction of tumor immunity by variants of folate binding protein
#3251Peptoids useful for the mineralization of apatite
#3252Peptide-based collagen modulators for wound healing and tissue repair
#3253Pea protein peptides with anti activity
#3254CD44v6-derived peptides for treating pancreatic cancer
#3255Linear peptide antibiotics
#3256Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof
#3257Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban
#3258Process for the preparation of leuprolide and its pharmaceutically acceptable salts
#3259CYSTEINE PROTEASE CAPTURING AGENTS
#3260PEPTIDES, CONSTRUCTS AND USES THEREFOR
#3261Treatment of IL-17 mediated disease by blocking SEFIR-SEFIR interactions
#3262PIGMENT STRUCTURES, PIGMENT GRANULES, PIGMENT PROTEINS, AND USES THEREOF
#3263PAR4 agonist peptides
#3264Compound and photoacoustic imaging contrast medium containing the compound
#3265Protease detection
#3266Prostate-specific membrane antigen antibody drug conjugates
#3267MUC-1 cytoplasmic domain peptides as inhibitors of cancer
#3268Peptides derived from viral proteins for use as immunogens and dosage reactants
#3269Peptide tyrosinase activators
#3270Preparation of Technetium-99M Tricarbonyl Labeled Glycine Monomer or Oligomer Containing Probes That Have Biomolecules and Its Application as Imaging Complex-Composition
#3271Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
#3272Methods and compositions for treating pain
#3273Vault complexes for cytokine delivery
#3274Gamma amino acid building blocks
#3275Novel Peptides and Analogs for Use in the Treatment of Macrophage Activation Syndrome
#3276Peptides effective in the treatment of conditions requiring the removal or destruction of cells
#3277Peptide inhibitors of caspase 2 activation
#3278Controlled-Released Peptide Formulations
#3279Salt and protease-resistance of antimicrobial peptide and the manufacture thereof
#3280Immunotherapy against several tumors including gastrointestinal and gastric cancer
#3281REPLIKIN SEQUENCES AND THEIR ANTIBODIES FOR DIAGNOSTICS, THERAPEUTICS, AND VACCINES AGAINST PRION AND NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER'S DISEASE
#3282Murine anti-NY-ESO-1 T cell receptors
#3283Compounds and methods for inhibiting cell death
#3284METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
#3285Manufacture of degarelix
#3286STABLE PEPTIDE-BASED FURIN INHIBITORS
#3287Compositions and methods for promoting wound healing and tissue regeneration
#3288Compounds which inhibit neuronal exocytosis
#3289PURIFICATION OF [18F] - FLUCICLATIDE
#3290Screening method for peptide binding to target molecule in pH-dependent manner
#3291Orally active, cell-penetrating homing peptide and methods of using same
#3292Novel JNK Inhibitor Molecules for Treatment of Various Diseases
#3293Alpha-helical peptidomimetic inhibitors and methods using same
#3294Protease assay
#3295Nanoemulsions
#3296TDF-related compounds and analogs thereof
#3297IMMUNOMODULATOR METALLOPEPTIDES (IMMPS) AND COMPOSITIONS CONTAINING SAME
#3298Tubulysin compounds, methods of making and use
#3299Protease assay
#3300FUSION PROTEINS FORMING TRIMERS